Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies.
DePoly is a chemical recycling company focused on addressing the challenges posed by plastic waste. Its innovative technology converts post-consumer PET plastic and polyester textiles into their primary raw materials at room temperature, eliminating the need for pre-washing, pre-sorting, or separating other plastics. This process enables the production of high-quality raw materials that can be reintegrated into the industry, facilitating the creation of new virgin-quality plastic products. By promoting this method, DePoly aims to contribute to a circular plastic economy, supporting sustainability and reducing environmental impact.
AICA SA specializes in developing robot-agnostic software aimed at simplifying the programming of robots through the use of artificial intelligence. Recognizing the complexity and time-consuming nature of traditional robot programming, the co-founders created a user-friendly software solution that significantly reduces computing time while employing advanced algorithms. This innovative approach allows for a modular setup that enhances the interaction between humans and robots, enabling clients to implement and manipulate robotic systems on-site with ease. AICA envisions a future where robots can take over dirty, dull, or dangerous tasks, allowing humans to focus on more creative and challenging work.
DPhi Space is focused on creating ridesharing platforms to make space access more democratic and affordable. The company aims to streamline the deployment of small satellites by integrating multiple payloads and coordinating launch schedules with various providers. This approach reduces the costs and complexities typically associated with satellite launches, allowing researchers to optimize capacity utilization and decrease dependency on dedicated launches. As a result, DPhi Space facilitates faster and more cost-effective deployment of both software and hardware in orbit, contributing to the advancement of spacefaring infrastructure.
Eleven Dynamics is a developer of software technology designed to automate industry quality control. The technology software provides solutions for designing and simulating. The processes include automatically programming measurement paths at optimal process time without the need for being a robotic expert, connecting all hardware in real time, and executing the measurement process. The software is used to create custom robotic solutions for clients.
Grand Resort Bad Ragaz is situated in the Heidiland holiday region of Eastern Switzerland. Europe’s leading wellbeing and medical health resort dates back to 1242. The health resort is supplemented by the renowned Medical Health Centre, as well as the Swiss Olympic Medical Center. The resort has two golf courses, the Kursaal Business & Events Center, a broad range of cultural activities, and its casino.
Embotech, short for embedded optimization technologies, was founded in September 2013. They strive to lead the market for numerical optimization solutions that will be integral part of tomorrow's decision making systems. The company is a spin-off of the Automatic Control Laboratory from ETH Zurich.
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
Somagenetix is a biotechnology company focused on developing innovative gene therapies for phagocyte-related illnesses, particularly targeting severe inherited immune diseases, immunodeficiency, neurodegeneration, and cancer with brain metastases. The company specializes in discovering and developing stem cells from bone marrow and utilizing lentiviral vectors to deliver therapeutic genes. This approach aims to correct the underlying genetic defects in patients by transplanting gene-corrected cells back into the body, ultimately providing a potential cure for various monogenic disorders. With a commitment to advancing the field of gene therapy, Somagenetix aims to lead in creating first-in-class treatments that address significant medical needs.
Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.
AskEarth is a geospatial intelligence platform that delivers real-time and accurate geospatial information to help users predict future environmental changes. Originating as a spin-off from the University of Zurich, ETH, and EPFL, AskEarth specializes in providing unique insights derived from daily satellite images. Its platform includes features that comply with the EU Deforestation Regulation, offering tools for exposure assessment, automatic deforestation monitoring, and reporting. Users can monitor various environmental phenomena, such as coastline changes, deforestation, glacier melting, and transportation patterns. Additionally, the platform serves as an accessible resource for verifying news articles and obtaining essential earth observation data, enabling clients to explore and understand the planet effortlessly.
Isochronic manufactures industrial robotic products for pick and place applications by transporting multiple parts simultaneously.
Calingo is a digital insurance platform that specializes in providing personalized insurance coverage at the point of sale. The company focuses on delivering customized insurance products designed to meet individual needs, ensuring transparency and tailored options for customers. By optimizing risk protection, Calingo enables users to access suitable insurance solutions at fair prices, enhancing the overall purchasing experience.
Complementa is a Swiss firm based in Saint Gallen, founded in 1984, that specializes in providing consolidated performance reporting, accounting, investment consulting, and investment control services. The firm assists investors by planning, designing, and monitoring their investment and financing processes, ensuring that they have the necessary support to make informed decisions.
Drone Harmony was founded in 2016 by a team of problem solvers with a passion for drones, software and automation. From their very early days, they have set out to tackle the mathematical and engineering challenges of enabling cost-effective deployment of drone technology in industries, where existing technologies were unable to deliver. Drone Harmony reinvents the way people fly drones commercially. Its 3D flight planning software turns anyone with a drone into an inspection professional. Sophisticated algorithms reduce complex industrial inspection tasks to automated and scalable workflows.
Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.
Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.
DataHow AG is a spin-off from ETH Zurich that specializes in data analytics and process modeling tailored for the biopharmaceutical and chemical industries. The company offers digital solutions and consulting services aimed at process monitoring, optimization, and scale-up. By focusing on improving the understanding of complex manufacturing processes, DataHow helps clients reduce effort, risks, and costs associated with process development and manufacturing. Through its technological expertise, the company enables clients to enhance their operational efficiency and ensure more effective management of their production processes.
Testmate Health is a medtech startup and an award-winning spin-off of the University of Geneva, focused on developing innovative healthcare solutions. The company has created a smartphone-compatible test kit that can diagnose diseases with identifiable DNA or RNA sequences, providing results directly at home in just minutes. Its first product is a rapid urine self-test for the four most common sexually transmitted diseases, addressing the urgent need for timely diagnosis, as one million new STDs are diagnosed daily. Traditional testing often requires lab work and can take up to seven days for results. Testmate Health's all-in-one kit is designed for ease of use, allowing users to obtain immediate results that can be scanned by a smartphone for quick access to treatment if necessary. The company is also working on additional test kits for other diseases, aiming to empower individuals to manage their health conveniently from home.
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
Bcomp Ltd. is a manufacturer based in Fribourg, Switzerland, specializing in natural fiber composites. Founded in 2003, the company produces innovative products such as ampliTex, a natural flax fiber available in various forms, bCores, a lightweight wood core, and powerRibs, a reinforcement material made from natural fibers. Bcomp's technologies, developed from years of research and patented innovations, allow for the creation of structural components that can effectively replace traditional materials like aluminum and carbon fiber. The company serves diverse industries, including sports, automotive, acoustics, aerospace, electronics, design, and leisure, focusing on enhancing efficiency in weight, rigidity, shock absorption, and damping. Bcomp collaborates closely with its customers to tailor solutions that meet specific needs while continuing to strengthen its research and development efforts through academic partnerships.
Autonomous Testing with Zero Flakiness. The TrueTest Technology and our AI-based virtual user makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach. We simplified automated testing massively and reduced time radically. With it, the automation and maintenance effort is reduced to a minimum: zero flakiness and the enlightening feeling of being in control of your automation and test scenarios. It's not about buzzwords and being one of the cool kids. Our mission was to solve the daily problems of test automation. And that's what we did. OUR TECHNOLOGY Stop losing your time on tasks automation should have eliminated The power of TestResults.io lies in its core, the TrueTest technology. It includes Visual Matching, Visual Sense, and Codified Expertise. Visual Matching Identifies elements in a technology-agnostic way through image convolution, text detection, and our unique ReverseOCR Visual Sense Identifies interaction position without hints to solve flakiness with spatial algorithms and automatic candidate selection. It doesn’t matter if the label is outside or inside, above, left from the field or anywhere else. It doesn’t matter if the position changes in a responsive layout. Visual Sense, always knows what label is related to which field. Codified Expertise Knows how to interact with elements through autonomous interactions and automatic verification.
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.
Cultivated Biosciences is a food production company focused on developing specialized fat ingredients derived from oleaginous yeast. This innovative approach aims to enhance the creaminess and mouthfeel of plant-based dairy products, such as cheese and yogurt, making them more appealing to consumers. The company's yeast-based ingredients provide a clean label and sustainable production process, mimicking the texture and color of traditional dairy while featuring properties like low lipid oxidation and natural emulsification. This enables the production of healthier, animal-free alternatives that cater to the growing demand for plant-based options.
Food Brewer AG is a Switzerland-based company specializing in the development of food and food ingredients through innovative plant cell culture technologies. By utilizing large-scale cultivation methods akin to beer brewing, Food Brewer offers alternatives to conventional agriculture, thereby addressing challenges related to geographic, climatic, and ethical uncertainties in food production. The company focuses on creating sustainable ingredients, including cocoa, coffee, nuts, and grains, which cater to the needs of the food industry. Through its research and development efforts, Food Brewer aims to provide clients with reliable and resource-efficient options for food sourcing.
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.
Qumea specializes in medical technology focused on discreet patient monitoring and fall prevention in healthcare settings. By integrating artificial intelligence with advanced 3D radar technology, Qumea offers a comprehensive solution that enhances patient safety while reducing the workload of caregivers. The company's system comprises a 3D radar sensor, cloud infrastructure, and a user-friendly application, creating an efficient early-warning mechanism that aids in effective mobility monitoring. This innovative approach not only enhances care quality but also leads to significant cost savings for hospitals and care institutions.
BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
Scientific Instrumentation and Services
Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.
Aesyra SA, founded in 2017 and based in Lausanne, Switzerland, specializes in the design and manufacture of medical devices focused on managing sleep disorders. The company's flagship product, AesyBite, is an intra-oral sensor that monitors and alleviates sleep bruxism, a condition characterized by teeth grinding during sleep. Aesyra's technology enables dental professionals to conduct intraoral measurements while patients sleep, allowing for the detection of bruxism and other sleep-related issues, such as obstructive sleep apnea. By providing accurate monitoring and biofeedback alternatives, Aesyra aims to help healthcare providers reduce damage to dental prostheses caused by occlusal problems and improve overall sleep quality for their patients.
Onena Medicines is a biotechnology company focused on developing innovative biological therapies to meet the significant clinical needs of breast cancer and other serious orphan diseases. The company utilizes a proprietary antibody drug discovery platform that leverages artificial intelligence to create custom antibodies with high selectivity and specificity. This platform is designed to reprogram cancer cells and modulate the activities of a novel set of growth factors known as dual smad inhibiting protein dips, which are believed to contribute to cancer growth and metastasis. By doing so, Onena Medicines aims to provide physicians with access to new treatment options in areas where there is a lack of effective therapies.
Helio provides a cloud-based platform that optimizes workload execution while minimizing carbon emissions. By utilizing containerized workloads and cloud-native principles, Helio effectively matches computing demands with available resources, allowing companies to carry out large-scale tasks such as 3D rendering and machine learning. The platform is designed with security features to facilitate safe interactions between users and the system. Helio's focus on carbon awareness aims to address the significant energy consumption of data centers, making it easier for businesses to operate sustainably while achieving cost-effective and scalable computing solutions.
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.
Tune Insight specializes in data security software that enables secure collaborations on sensitive data among multiple organizations. The company's innovative platform employs advanced analytics, privacy measures, and encryption technologies to facilitate federated learning, allowing organizations to collaboratively extract insights while maintaining control over their data. By fostering a secure environment for data sharing, Tune Insight helps organizations make informed decisions together, leveraging collective intelligence without compromising data privacy.
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
Nezasa is a developer of a travel optimization platform that enables travel brands to offer a comprehensive booking solution for multi-product and multi-stop itineraries. By combining the functionalities of a traditional travel agency with the efficiency of an online portal, Nezasa's tools facilitate seamless planning and real-time booking of personalized trips. Their TripBuilder feature allows users to create hyper-personalized travel packages, while TripBooster extends these capabilities to enhance in-destination upselling opportunities. The platform leverages standardized and customizable application programming interfaces hosted in a secure cloud environment, making it easy for tour operators and travel retailers to automate the customization and booking processes for their clients. With a focus on deep integration and an interactive user experience, Nezasa caters to large travel operators, providing them with enterprise-grade solutions to enhance their service offerings throughout the entire travel lifecycle.
DePoly is a chemical recycling company focused on addressing the challenges posed by plastic waste. Its innovative technology converts post-consumer PET plastic and polyester textiles into their primary raw materials at room temperature, eliminating the need for pre-washing, pre-sorting, or separating other plastics. This process enables the production of high-quality raw materials that can be reintegrated into the industry, facilitating the creation of new virgin-quality plastic products. By promoting this method, DePoly aims to contribute to a circular plastic economy, supporting sustainability and reducing environmental impact.
Distran, a spin-off from the Autonomous System Lab at ETH Zurich, specializes in the development of advanced acoustic sensors aimed at enhancing safety for industrial workers and minimizing environmental impact. The company focuses on manufacturing ultrasound cameras that cater to various sectors, including oil and gas, power generation, and chemical engineering. Distran's innovative phased-array sensors address the limitations of traditional acoustic sensors, which often struggle to function effectively in noisy industrial environments. By spatially filtering sounds, these sensors enable the detection of defects such as leaks or discharges from a safe distance, thereby allowing clients to protect their workforce and reduce their ecological footprint.
UniSieve Ltd, founded in 2018 and headquartered in Zurich, Switzerland, develops and manufactures advanced molecular sieving membranes that enable efficient separation solutions across various industries. The company's innovative platform technology integrates molecular sieves with polymeric membranes to facilitate applications such as chemical feedstock purification, biogas upgrading, gas and liquid separation, and specialized uses in sensing and space-related projects. UniSieve's technology is designed to enhance energy efficiency in size-based purification processes, supporting clients in reducing carbon dioxide emissions, improving recycling rates, and lowering operational costs.
Nexoya AG is a Zurich-based company founded in 2018 that specializes in developing a digital marketing platform designed to enhance marketing performance through artificial intelligence. The platform provides insights into marketing data and actionable advice, allowing clients to optimize their marketing campaigns and effectively allocate their advertising budgets across various channels. By collecting key performance indicators from tools such as Google Ads and Facebook, Nexoya's AI-driven algorithm evaluates the most cost-effective use of advertising funds, leading to a potential increase in return on ad spend. The platform also features predictive analytics, cross-channel reporting, and anomaly detection, which assist clients in planning and executing their marketing strategies with maximum efficiency.
Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.
tado° GmbH is a Munich-based company that specializes in developing and marketing home climate control systems. Founded in 2010, the company offers a combination of hardware and software solutions designed to enhance the efficiency of heating and cooling systems in residential and small business environments. tado°'s innovative products adjust to the behavior of residents in real time while also considering weather forecasts and building characteristics. The company distributes its offerings through both retail stores and online platforms, positioning itself at the intersection of technology and sustainable energy management in the cleantech market. With an additional office in London, tado° continues to focus on integrating Internet of Things technology into everyday climate control solutions.
Correntics operates a climate risk assessment platform aimed at enhancing the resilience of global supply chains. By employing a data-driven approach, the company provides clients with a comprehensive overview of their supply chains, from raw material availability to final delivery. Its platform utilizes real-time hazard and probabilistic risk modeling to generate forward-looking scenarios, enabling clients to gain actionable insights that help mitigate potential disruptions. Correntics' expertise supports businesses in reducing risks associated with climate change and other emerging threats, ultimately fostering improved operational efficiency and financial stability while ensuring sustainability in their activities.
Medyria AG is a Swiss medtech company based in Winterthur, specializing in sensor-based catheter navigation and sensing systems for cardiovascular procedures. Founded in 2012, the company offers a range of innovative products, including a catheter positioning system designed for X-ray and C-dye free minimally invasive interventions, as well as Flowcath, which measures blood flow. Their Trackcath technology processes flow data to enhance catheter tracking, while their OEM flow sensor utilizes proprietary technology for measuring blood and physiological fluid flow. Medyria aims to enhance the safety and effectiveness of endovascular procedures, ultimately improving patient outcomes and reducing procedural complications and costs.
Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of high-efficiency solar panels. The company has achieved significant advancements in solar technology, with modules reaching a record efficiency of 29 percent, which allows for a reduction in residential solar electricity costs to below 0.1 $/kWh. Insolight's innovative optical technology enhances efficiency while maintaining the simplicity of installation comparable to standard flat panels. The company's solar systems also incorporate an integrated tracking method to optimize energy capture, maximizing solar utility for agricultural applications. Insolight's business model focuses on developing intellectual property, overseeing wholesale distribution, and outsourcing manufacturing, ensuring a streamlined approach to delivering cost-effective solar solutions. The technology has been validated by reputable institutions, demonstrating its potential for widespread impact in both residential and agricultural sectors.
TerraRad Tech specializes in the development and marketing of remote sensing devices designed to optimize agricultural efficiency and sustainability. The company offers drone and vehicle-mounted sensors that measure soil moisture and crop water content, providing actionable data that helps reduce water usage in farming. Their turfRad line specifically targets golf courses, utilizing a SaaS model combined with sensor hardware to achieve significant irrigation water savings. By developing advanced microwave radiometers for both UAV-based and ground-based systems, TerraRad Tech aims to enhance soil moisture measurement capabilities, ultimately supporting more efficient agricultural practices.
Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
Vestr is a technology company that specializes in providing a software-as-a-service platform designed for the creation and management of actively managed investment products. Its end-to-end solution addresses the complexities of active management by digitizing the entire value chain, allowing issuers and portfolio managers to concentrate on their core activities. The platform includes tools for portfolio management, order execution, and performance reporting, enabling clients to efficiently manage their investments, make informed decisions, and mitigate risks. By streamlining processes such as portfolio rebalancing and investor reporting, Vestr enhances operational efficiency without directly issuing its own structured products.
Avelo mission is to save lives by bringing fast and actionable infectious disease diagnoses to primary care.
Skribble is a platform for electronic signatures that presupposes the identification of the signatures. The platform provides the legally suitable electronic signature for every type of contract even if the law requires the same legal weight as a handwritten signature. It allows signing documents electronically with just a few clicks legally binding in accordance with Swiss & EU law. Skribble was founded in 2018 and is headquartered in Zurich, Switzerland.
Piomic is a developer of a non-invasive medical device aimed at treating chronic wounds, particularly in patients with hard-to-heal leg and foot ulcers. The company's flagship product, the COMS® One Therapy System, is a portable, hand-held device that uses optical and magnetic stimulation technologies to promote wound healing. Clinical studies demonstrate that this device is safe and effective, leading to accelerated wound closure, reduced pain, and improved quality of life for patients. Designed for ease of use, the device features a single-button operation and can be utilized in various settings, including stationary and ambulatory facilities, as well as in patients’ homes. By focusing on a therapy that provides significant benefits, Piomic seeks to improve the treatment outcomes for individuals suffering from chronic wounds and alleviate the cost burden on healthcare systems.
Pipra is a MedTech start-up focused on addressing the significant issue of delirium in healthcare, particularly Post-Operative Delirium (POD), which affects around 20% of patients over 60 and incurs substantial costs for hospitals and insurers. The company has developed an AI-driven clinical decision support software that enables healthcare professionals to identify high-risk patients prior to surgery. This pre-operative risk assessment tool utilizes standard medical data and can be accessed via web or app, providing a score-based risk assessment in under two minutes. By highlighting patients at risk, Pipra's solution allows for the implementation of targeted interventions that have been shown to reduce the incidence of POD by 53%. Currently, Pipra's technology is operational in three hospitals, with plans for deployment in an additional 22 hospitals across Europe. The company's advisory board includes experts from renowned institutions such as Johns Hopkins, Harvard, and Cornell, further enhancing its credibility in the field.
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.
Smeetz SA is an online booking platform based in Lausanne, Switzerland, that specializes in the leisure and entertainment industry. Founded in 2016, the company offers a comprehensive suite of solutions designed to streamline event organization and promotion. Its platform incorporates AI-powered tools for sales, marketing, reservation management, ticket booking, and distribution. Smeetz employs dynamic pricing strategies and data analytics to help venues optimize revenue and enhance operational efficiency. The platform also includes features such as a booking widget, cross-channel sales, access control, payment methods, and customizable ticket solutions. By unifying commerce and embedding financial tools, Smeetz aims to transform the customer experience in the leisure sector, enabling businesses to thrive in a competitive environment.
Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.
Isochronic manufactures industrial robotic products for pick and place applications by transporting multiple parts simultaneously.
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.
9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in manufacturing 3D printers that produce carbon composite parts. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Utilizing its proprietary Additive Fusion Technology (AFT), 9T Labs enables manufacturers to create lightweight structural components with precise 3D fiber orientation, facilitating mass production at reduced costs. The intuitive design software supports optimal fiber placement, while automated production equipment enhances efficiency across the entire value chain. The technology allows for the efficient production of high-performance parts, including applications in drones and prosthetics, making it accessible for engineers and manufacturers alike.
Memo Therapeutics AG, based in Basel, Switzerland, specializes in innovative antibody discovery and immune repertoire analysis. The company utilizes its proprietary MemoMAB platform, which generates a recombinant in vitro copy of an individual's B cell or antibody repertoire, creating extensive libraries that represent unique immune responses. These libraries are expected to contain a vast array of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics applies this technology in its own antibody lead discovery programs and partners with other entities to enhance research and development in the fields of viral infections and cancer. Through its advancements, Memo Therapeutics aims to significantly improve therapeutic options for patients.
Odne is a medtech startup based in Renens, Switzerland, specializing in innovative implant technology for endodontics. Founded in 2018, the company focuses on the development of light-active medical fillers that facilitate the creation of implants directly within the body through a minimally invasive approach. This technology allows physicians to perform surgeries using an access channel of less than half a millimeter in diameter, significantly reducing surgical time and enhancing patient outcomes. By providing elegant solutions for complex procedures, Odne aims to improve the efficiency and effectiveness of medical interventions in the field of endodontics.
Drone Harmony was founded in 2016 by a team of problem solvers with a passion for drones, software and automation. From their very early days, they have set out to tackle the mathematical and engineering challenges of enabling cost-effective deployment of drone technology in industries, where existing technologies were unable to deliver. Drone Harmony reinvents the way people fly drones commercially. Its 3D flight planning software turns anyone with a drone into an inspection professional. Sophisticated algorithms reduce complex industrial inspection tasks to automated and scalable workflows.
Nanoleq AG, established in 2017 and based in Zurich, Switzerland, specializes in the development and manufacturing of innovative electric cables using stretchable electronics. As a spinoff from ETH Zurich, the company focuses on integrating electronic functionalities into textiles, particularly for health monitoring. Its products utilize advanced conductive silicone technology to create soft sensors capable of recording vital signs such as heartbeat, electrocardiograms, and breathing patterns through comfortable and washable garments. These sensors are designed for various applications, including healthcare, sports, and workwear, with the aim of setting a standard in the health-monitoring textile market. Nanoleq is committed to facilitating the rapid development and widespread adoption of smart textiles across multiple sectors, including robotics and aerospace.
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland.
xorlab AG is a Swiss cybersecurity company established in 2015, specializing in advanced defense solutions for email communication. The company has developed the xorlab ActiveGuard platform, which protects organizations from sophisticated threats such as spear-phishing, impersonation, ransomware, and zero-day exploits. By analyzing and learning from legitimate communication behaviors, ActiveGuard enhances email security for businesses, particularly in the financial services and high-tech sectors. Additionally, xorlab offers xorlab ThreatAnalyst, which supports security operations teams in identifying and mitigating emerging attacks. With a dedicated team of 14 professionals, xorlab safeguards over 50,000 mailboxes and processes more than 1.5 million emails daily, helping clients reduce the risk of breaches and lower operational costs through automation and proactive defense strategies.
Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.
Scewo AG, founded in 2017 and headquartered in Winterthur, Switzerland, specializes in designing and manufacturing innovative electric wheelchairs tailored for individuals with mobility impairments. The company has developed a unique stair-climbing wheelchair that integrates both wheels and tracks, allowing for enhanced maneuverability over various terrains, including curbs, tram tracks, grass, and uneven surfaces. This self-balancing wheelchair features an active control system that maintains stability and levelness, enabling users to navigate obstacles with ease. Users can control the chair through a joystick or by shifting their body weight, providing a versatile solution to improve mobility and independence for those with disabilities.
Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.
RoomPriceGenie AG, founded in 2017 and headquartered in Steinhausen, Switzerland, specializes in developing revenue management software for hotels, apartments, and vacation rentals. The platform employs advanced dynamic pricing algorithms and real-time analytics to optimize room pricing based on market demand and occupancy levels. It offers features such as automated pricing adjustments, manual control options, and seamless integration with various property management systems and channel managers. This allows users to update all prices with a single click, enhancing operational efficiency. RoomPriceGenie is designed for small to medium-sized hotels, providing a user-friendly interface and excellent customer support to help clients boost their revenue effectively.
Eldico Scientific AG, founded in 2019 and based in Villigen, Switzerland, specializes in the development and manufacturing of electron diffractometers designed for the analysis of solid compounds. The company's innovative instruments enable researchers in various fields, including pharmaceuticals, agrochemicals, and advanced materials, to characterize nano-crystalline systems that were previously difficult to measure. By providing tools for nano-crystallographic investigations, Eldico aims to enhance the efficiency and cost-effectiveness of structural information gathering, thereby accelerating the drug discovery and development process. The company has made significant strides in the field, achieving proof of concept for its technology in collaboration with leading Swiss research institutions, and has received recognition for its contributions to scientific advancement.
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.
Nexoya AG is a Zurich-based company founded in 2018 that specializes in developing a digital marketing platform designed to enhance marketing performance through artificial intelligence. The platform provides insights into marketing data and actionable advice, allowing clients to optimize their marketing campaigns and effectively allocate their advertising budgets across various channels. By collecting key performance indicators from tools such as Google Ads and Facebook, Nexoya's AI-driven algorithm evaluates the most cost-effective use of advertising funds, leading to a potential increase in return on ad spend. The platform also features predictive analytics, cross-channel reporting, and anomaly detection, which assist clients in planning and executing their marketing strategies with maximum efficiency.
Futurae, established in 2016 as a spin-off from ETH Zurich, specializes in enhancing the authentication process for users and businesses. The company provides a comprehensive Authentication Platform that incorporates AI-driven solutions and adheres to regulatory standards, such as PSD2 and SCA. Futurae's offerings aim to reduce user friction and improve the overall user experience while simultaneously lowering support costs for organizations. Serving over 130 clients, including banks, insurance companies, online retailers, and digital wallets, Futurae enables real-time fraud detection and facilitates seamless user journeys with adaptive online security measures.
Apiax AG, founded in 2017 and based in Zürich, Switzerland, specializes in developing digital tools for managing financial regulations. The company provides an embedded compliance solution that allows financial institutions, including banks and FinTech companies, to transform complex regulations into user-friendly digital compliance rules. This technology enables clients to integrate compliance seamlessly into their existing applications and processes, facilitating faster decision-making and addressing pressing regulatory questions. By leveraging a high-performance architecture and machine learning, Apiax helps organizations navigate regulatory challenges, seize business opportunities, and reduce compliance costs. The company's presence extends beyond Switzerland, with additional offices in Lisbon and London.
Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.
Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders. The company also develops breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of the natural functioning of the brain. The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran. There is a high demand for new pharmacological treatments in this area especially for certain diseases such as post-traumatic stress disorder (PTSD) which has a high unmet medical need.
Voliro is a pioneer in mobile robotics, specializing in innovative solutions for work at heights through advanced flying robots. These robots are designed for contact-based tasks, leveraging a proprietary tiltable rotor system that transforms conventional drones into versatile robotic platforms capable of precise environmental interaction. Their unique 360° drone design enables inspections on curved and sloped surfaces, setting them apart in the market. Voliro's aerial robots can be equipped with various payloads, including Non-Destructive Testing (NDT) sensors and Lightning Protection System (LPS) sensors, to enhance the efficiency and reliability of inspections. The company focuses on delivering automated nondestructive testing inspections, ultrasonic thickness measurements, and thermal imaging, allowing clients to achieve asset inspection and monitoring services that are safer, faster, and more cost-effective.
Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of high-efficiency solar panels. The company has achieved significant advancements in solar technology, with modules reaching a record efficiency of 29 percent, which allows for a reduction in residential solar electricity costs to below 0.1 $/kWh. Insolight's innovative optical technology enhances efficiency while maintaining the simplicity of installation comparable to standard flat panels. The company's solar systems also incorporate an integrated tracking method to optimize energy capture, maximizing solar utility for agricultural applications. Insolight's business model focuses on developing intellectual property, overseeing wholesale distribution, and outsourcing manufacturing, ensuring a streamlined approach to delivering cost-effective solar solutions. The technology has been validated by reputable institutions, demonstrating its potential for widespread impact in both residential and agricultural sectors.
Vestr is a technology company that specializes in providing a software-as-a-service platform designed for the creation and management of actively managed investment products. Its end-to-end solution addresses the complexities of active management by digitizing the entire value chain, allowing issuers and portfolio managers to concentrate on their core activities. The platform includes tools for portfolio management, order execution, and performance reporting, enabling clients to efficiently manage their investments, make informed decisions, and mitigate risks. By streamlining processes such as portfolio rebalancing and investor reporting, Vestr enhances operational efficiency without directly issuing its own structured products.
Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.
Metaco is a Swiss company that specializes in providing institutional digital asset management solutions. It offers a comprehensive orchestration platform designed for financial institutions to issue, secure, manage, and trade digital assets. Metaco's platform supports the entire lifecycle of asset tokens, including the management of cryptocurrencies, tokens, and smart contracts. By utilizing advanced blockchain technologies, the company ensures a secure and efficient environment for digital asset management. Additionally, Metaco's solutions incorporate risk management to balance asset security and liquidity, allowing institutions to connect with over 50 exchanges, brokers, and market makers, thereby facilitating seamless trading across various asset classes such as equities, bonds, and derivatives.
Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.
xorlab AG is a Swiss cybersecurity company established in 2015, specializing in advanced defense solutions for email communication. The company has developed the xorlab ActiveGuard platform, which protects organizations from sophisticated threats such as spear-phishing, impersonation, ransomware, and zero-day exploits. By analyzing and learning from legitimate communication behaviors, ActiveGuard enhances email security for businesses, particularly in the financial services and high-tech sectors. Additionally, xorlab offers xorlab ThreatAnalyst, which supports security operations teams in identifying and mitigating emerging attacks. With a dedicated team of 14 professionals, xorlab safeguards over 50,000 mailboxes and processes more than 1.5 million emails daily, helping clients reduce the risk of breaches and lower operational costs through automation and proactive defense strategies.
Skribble is a platform for electronic signatures that presupposes the identification of the signatures. The platform provides the legally suitable electronic signature for every type of contract even if the law requires the same legal weight as a handwritten signature. It allows signing documents electronically with just a few clicks legally binding in accordance with Swiss & EU law. Skribble was founded in 2018 and is headquartered in Zurich, Switzerland.
PXL Vision AG, founded in 2017 and headquartered in Zurich, Switzerland, specializes in the design and development of identity verification and customer onboarding software solutions. Its flagship product, Daego, employs advanced computer vision and machine learning technologies to create trusted digital identities. This cross-platform solution is tailored to meet the needs of various industries, including insurance, fintech, and healthcare, by automating the verification of identity documents and performing facial biometric checks to ensure that users are legitimate and the rightful owners of their documents. By facilitating secure and efficient customer onboarding, PXL Vision aims to enhance conversion rates, reduce costs associated with compliance, and mitigate identity fraud. With research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, PXL Vision is dedicated to establishing a foundation of trust in digital interactions through unbiased and verifiable identities.
Livet designs and engineers medical devices. They include information on medical devices; a designed LED light source is built-in; and endoscopic examinations can be easily performed simply by connecting to a PC for monitoring.
Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete the clinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
AVAtronics is developing noise-canceling technology.
Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies.
Klepsydra Technologies GmbH, founded in 2017 and based in Zurich, Switzerland, specializes in software engineering and cloud computing tools for embedded systems. The company provides a lightweight, platform-agnostic software development toolset aimed at facilitating the creation of high-performance applications in sectors such as aerospace, robotics, and smart mobility. Klepsydra's offerings are designed to accelerate the development of complex embedded software while optimizing computational performance for demanding tasks, such as sensor fusion and image processing. By enabling faster and more accessible innovation processes, Klepsydra serves as a valuable resource across various industries, contributing to advancements in autonomous technologies and other computationally intensive applications.
Archilyse, founded in 2017, is a PropTech start-up that offers holistic numeric architecture analysis as an easy to use Software-as-a-Service solution. By doing so, Archilyse provides information necessary for optimising a multitude of processes in every step of the real estate lifecycle. To produce knowledge based on data Archilyse uses four generic power-simulations, such as view, geometrical, connectivity and physical analysis, from which countless others can be derived. Their results provide the most comprehensive view on architecture currently available worldwide. This is how it works: 2D floor plans in the form of PDFs or building image files are converted to 3D BIM-Light models and geo-referenced. Using API (Application Program Interface) calls, professional users can analyse building models drawn from algorithms which translated the latest scientific findings into formulas. The results are presented to users in easy-to-read heatmaps or can be exported in the form of key figure tables for further processing. This process renders portfolio digitalisation profitable for the first time. Archilyse uses the underutilized potential of digitization in the real estate industry and thus eliminates the prevailing information imbalance between real estate professionals and layman, thereby enabling the maximization of benefits for all stakeholders in real estate.
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.
Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.
Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.
Apiax AG, founded in 2017 and based in Zürich, Switzerland, specializes in developing digital tools for managing financial regulations. The company provides an embedded compliance solution that allows financial institutions, including banks and FinTech companies, to transform complex regulations into user-friendly digital compliance rules. This technology enables clients to integrate compliance seamlessly into their existing applications and processes, facilitating faster decision-making and addressing pressing regulatory questions. By leveraging a high-performance architecture and machine learning, Apiax helps organizations navigate regulatory challenges, seize business opportunities, and reduce compliance costs. The company's presence extends beyond Switzerland, with additional offices in Lisbon and London.
Picstars AG operates an online platform that connects brands with influencers and advertisement content creators, specializing in the sponsorship of brand ambassadors, particularly athletes. Founded in 2014 and based in Zürich, Switzerland, Picstars allows companies to identify suitable talents in sports and lifestyle to promote their campaigns via social media. The platform facilitates the creation of marketing campaigns and provides tools for performance tracking, enabling brands to measure the success of their influencer partnerships effectively. By streamlining the matchmaking process between brands and influencers, Picstars enhances the efficiency of marketing strategies in the digital age.